RAP 0.00% 20.5¢ resapp health limited

Ann: Update on US FDA De Novo Classification Request, page-37

  1. Dhm
    2,380 Posts.
    lightbulb Created with Sketch. 3492
    Gutted. But if we can demonstrate that benefits far outweigh potential harm, then hopefully this Titanic can be turned around. I'm not so worried about Sanofi, but I really would like to know their reasons.

    We desperately need a conference call so management can shed further light on this fiasco.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.